共 374 条
[1]
Vellayappan BA(2018)The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases Expert Rev Anticancer Ther 18 887-900
[2]
Chao ST(2020)Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review JAMA Oncol 6 567-577
[3]
Foote M(2021)Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial Lancet Oncol 29 e119-e125
[4]
Guckenberger M(2017)Stereotactic ablative body radiotherapy for the treatment of spinal oligometastases Clin Oncol (R Coll Radiol) 393 2051-2058
[5]
Redmond KJ(2019)Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial Lancet 164 98-103
[6]
Chang EL(2021)An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases Radiother Oncol 152 173-182
[7]
Glicksman RM(2021)Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference J Neurooncol 2011 979214-435
[8]
Tjong MC(2011)Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review Int J Surg Oncol 27 428-581
[9]
Neves-Junior WFP(2017)Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review J Neurosurg Spine 30 575-580
[10]
Spratt DE(1994)Radiation myelopathy following single courses of radiotherapy and retreatment Int J Radiat Oncol Biol Phys 53 574-248